Search Results

The Budget for Fiscal Year 2008
This report discusses the Food and Drug Administration's (FDA's) FY2009 budget request of $2.676 billion that would provide a 17.9% increase ($406 million) over FY2008. It includes an overview and breakdowns for specific programs: Foods Program, Human Drugs Program, Biologics program, Animal Drugs and Feed Program, and the Devices and Radiological Health Program.
Increases in Tricare Costs: Background and Options for Congress
In its FY2007 budget submission, the Department of Defense (DOD) proposed increases in Tricare enrollment fees, deductibles, and pharmacy co-payments for retired beneficiaries not yet eligible for Medicare. The raises were justified by DOD as necessary to constrain the growth of health care spending as a proportion of the overall defense budget in the next decade. Many beneficiaries argued that the proposed hikes were unfair and unnecessary. The FY2007 Defense Authorization Act prohibited increases in premiums, deductibles, and co-payments prior to September 30, 2007. The FY2008 National Defense Authoriztion Act extended the prohibition of increases in co-payments and enrollment fees until October 2008 and Congress may move to extend them further.
The Defense Production Act of 1950: History, Authorities, and Reauthorization
This report examines some of the history of the Defense Production Act of 1950 (DPA), focusing primarily on its creation and most recent legislative reauthorization. It also discusses the foremost active authorities of the DPA.
The Defense Production Act of 1950: History, Authorities, and Reauthorization
This report examines some of the history of the Defense Production Act of 1950 (DPA), focusing primarily on its creation and most recent legislative reauthorization. It also discusses the foremost active authorities of the DPA.
The Defense Production Act of 1950: History, Authorities, and Reauthorization
This report examines some of the history of the Defense Production Act of 1950 (DPA), focusing primarily on its creation and most recent legislative reauthorization. It also discusses the foremost active authorities of the DPA.
The Defense Production Act of 1950: History, Authorities, and Reauthorization
This report examines some of the history of the Defense Production Act of 1950 (DPA), focusing primarily on its creation and most recent legislative reauthorization. It also discusses the foremost active authorities of the DPA.
The Defense Production Act of 1950: History, Authorities, and Considerations for Congress
This report examines some of the extensive history of the Defense Production Act of 1950 (DPA), focusing primarily on its creation and most recent legislative reauthorization. This report also identifies relevant delegations of the President's DPA authorities made in Executive Order (E.O.) 13603 -- National Defense Resources Preparedness -- and provides a brief overview of issues Congress may consider in its oversight.
Policy Issues in the General Motors Vehicle Recall
This report discusses the National Highway Traffic Safety Administration (NHTSA) process by which vehicle safety defects are identified and vehicles are recalled, as well as the impact that the 2009 GM bankruptcy may have on liability for this defect.
Prescription Drug User Fee Act of 1992: Effects on Bringing New Drugs to Market
No Description Available.
The Consumer Financial Protection Bureau (CFPB): A Legal Analysis
This report provides an overview of the regulatory structure of consumer finance under existing federal law before the Dodd-Frank Act went into effect, and examines arguments for modifying the regime in order to more effectively regulate consumer financial markets. It then analyzes how the CFP Act changes the legal structure, with a focus on the Bureau's organization; the entities and activities that fall (and do not fall) under the Bureau's supervisory, enforcement, and rulemaking authorities; the Bureau's general and specific rulemaking powers and procedures; and the Bureau's funding.
Financial Regulatory Reform: Analysis of the Consumer Financial Protection Agency (CFPA) as Proposed by the Obama Administration and H.R. 3126
This report provides a brief summary of the President's Consumer Financial Protection Agency Act of 2009 (the CPFA Act or the Act) and delineates some of the substantive differences between it and H.R. 3126, as introduced. It then analyzes some of the policy implications of the proposal, focusing on the separation of safety and soundness regulation from consumer protection, financial innovation, and the scope of regulation. The report then raises some questions regarding state law preemption, sources of funding, and rule-making procedures that the Act does not fully answer.
Financial Regulatory Reform: Analysis of the Consumer Financial Protection Agency (CFPA) as Proposed by the Obama Administration and H.R. 3126
This report provides a brief summary of the Obama Administration's Consumer Financial Protection Agency Act of 2009 (CFPA) and delineates some of the substantive differences between it and H.R. 3126, as ordered to be reported by the House Financial Services Committee, as well as the version that was ordered to be reported by the House Energy and Commerce Committee.
Financial Regulatory Reform: Analysis of the Consumer Financial Protection Agency (CFPA) as Proposed by the Obama Administration and H.R. 3126
This report provides a brief summary of the President's Consumer Financial Protection Agency Act of 2009 and delineates some of the substantive differences between it and H.R. 3126, as introduced. It then analyzes some of the policy implications of the proposal, focusing on the separation of safety and soundness regulation from consumer protection, financial innovation, and the scope of regulation.
The Chained Consumer Price Index: How Is It Different?
This report is categorized into four categories: (I) Introduction, (II) Methodological Differences, (III) Statistical Differences, (IV) Policy Consideration.
International political implementations of commodity policy
This report presents International political implementations of commodity policy which can stabilize prices and assure supply to the benefit of both producer and consumer.
Products Liability: A Legal Overview
This report discusses products liability, which refers to the liability of a manufacturer or seller for injury caused by his product to the person or property of a buyer or third party. Legal developments starting in the 1960s, particularly the adoption of strict tort liability, have made it substantially easier for persons injured by defective products to recover damages.
Asbestos Compensation Act of 2000
This report summarizes H.R. 1283, 106th Congress, the Asbestos Compensation Act of 2000, as ordered to be reported with amendments by the House Committee on the Judiciary on March 16, 2000. The bill would create an administrative procedure for asbestos liability claims.
Federal Advertising Law: An Overview
This report provides a brief overview of federal law with respect to five selected advertising issues: alcohol advertising, tobacco advertising, the Federal Trade Commission Act, advertising by mail, and advertising by telephone. There are numerous federal statutes regulating advertising that do not fit within any of these categories; as random examples, the Food, Drug, and Cosmetic Act requires disclosures in advertisements for prescription drugs ; the Truth in Lending Act governs the advertising of consumer credit ; and a federal criminal statute makes it illegal falsely to convey in an advertisement that a business is connected with a federal agency.
Homeland Security Act of 2002: Tort Liability Provisions
The Homeland Security Act of 2002, P.L. 107-296 (H.R. 5005), contains the following provisions that limit tort liability, and this report examines each of them 1) Section 304,863,8901201,1402,1714-1717.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
No Description Available.
Products Liability: A Legal Overview
Report on the differing viewpoints manufacturers and consumers have on product liability, including background and analysis of the issues, relevant legislation, hearings, reports, and more.
Protection of Lawful Commerce in Arms Act, H.R. 1036, 108th Congress: Legal Analysis
No Description Available.
Protection of Lawful Commerce in Arms Act, H.R. 1036 and S. 659, 108th Congress: Legal Analysis
No Description Available.
Protection of Lawful Commerce in Arms Act, H.R. 1036, S. 659, S. 1805, S. 1806, 108th Congress: Legal Analysis
No Description Available.
Tobacco Advertising: The Constitutionality of Limiting its Tax Deductibility
No Description Available.
Tobacco Advertising: Whether the FDA's Restrictions Violate Freedom of Speech
No Description Available.
Tobacco Marketing and Advertising Restrictions in S. 1415, 105th Congress: First Amendment Issues
No Description Available.
Tobacco Marketing and Advertising Restrictions in S. 1648, 105th Congress: First Amendment Issues
No Description Available.
Products Liability: A Legal Overview
No Description Available.
The Liability Insurance Crisis
This report discusses liability insurance crisis, including complaints from businesses, professionals , and municipalities as well threat of lawsuits.
The Liability Insurance Crisis
This report discusses liability insurance crisis, including complaints from businesses, professionals , and municipalities as well threat of lawsuits.
Attorneys' Fees in the State Tobacco Litigation Cases
In the past few years, many states have filed complaints against the tobacco industry in state court to recover Medicaid costs paid by the states to treat their citizens for tobacco related illnesses. The states are also attempting to recover other damages, such as punitive damages, against the tobacco industry. For various reasons, the states have hired private attorneys to assist the state Attorneys General in prosecuting these cases. In most cases, the retention of private counsel has included a fee agreement specifying the amount of compensation that these attorneys will receive for their services. These agreements are not uniform among the states, but most tend to provide some form of contingency fee arrangement. Some of these states have developed a sliding scale contingency fee schedule which varies with the amount of time spent on the litigation and whether a trial has begun. This report briefly summarizes the different fee agreements that the states have with private counsel.
Steel: Price and Policy Issues
Steel prices remain at historically elevated levels. The rapid growth of steel production and demand in China is widely considered as a major cause of the increases in both steel prices and the prices of steelmaking inputs. Steel companies have achieved much greater pricing power, in part through an ongoing consolidation of the industry
Ecstasy: Actions of the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
Ecstasy: Actions of the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
Ecstasy: Actions of the 107th Congress to Control MDMA
Legislation has been proposed in the 107th Congress to combat the use and abuse of Ecstasy (MDMA) and other “club drugs.” In a 2001 survey, 12% of 12th graders reported ever having taken the drug. The Ecstasy Anti-Proliferation Act of 2000, enacted by the 106th Congress, directed the U.S. Sentencing Commission to increase penalties for Ecstasy offenses. As of March 2001, MDMA penalties became more severe than for powder cocaine but less severe than for heroin.
Back to Top of Screen